The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 15 July 2008, www.theannals.com, DOI 10.1345/aph.1K680.
The Annals of Pharmacotherapy: Vol. 42, No. 9, pp. 1333-1339. DOI 10.1345/aph.1K680
© 2008 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, S. W
Right arrow Articles by Nelson, L. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, S. W
Right arrow Articles by Nelson, L. S

Acetaminophen Overdose with Altered Acetaminophen Pharmacokinetics and Hepatotoxicity Associated with Premature Cessation of Intravenous N-Acetylcysteine Therapy

Silas W Smith, MD

at time of writing, Senior Fellow, Medical Toxicology, New York City Poison Control Center, New York, NY; Department of Emergency Medicine, School of Medicine, New York University, New York, NY; now, Assistant Professor, Emergency Medicine, School of Medicine, New York University

Mary Ann Howland, PharmD

Clinical Professor of Pharmacy, College of Pharmacy, St. John's University, New York, NY; Adjunct Professor of Emergency Medicine, School of Medicine, New York University; Consultant, New York City Poison Control Center; Consultant, Bellevue Hospital Center Emergency Department, New York, NY

Robert S Hoffman, MD

Associate Professor, Emergency Medicine and Medicine (Clinical Pharmacology), School of Medicine, New York University; Director, New York City Poison Control Center

Lewis S Nelson, MD

Associate Professor, Emergency Medicine, School of Medicine, New York University; Director, Medical Toxicology Fellowship Program and Associate Director, New York City Poison Control Center

Reprints: Dr. Smith, 455 First Ave., Room 123, New York, NY 10016, fax 212/447-8223, Silas.Smith{at}nyumc.org

OBJECTIVE: To report a case of erratic absorption, double peak serum concentrations, and hepatotoxicity following premature cessation of intravenous N-acetylcysteine (NAC) treatment in the setting of a massive acetaminophen overdose.

CASE SUMMARY: A 78-year-old man reportedly ingested approximately 96 immediate-release acetaminophen 500-mg tablets (48 g) over a one-hour period in an apparent suicide attempt. The acetaminophen concentration at 2.25 hours was 264 µg/mL. Intravenous NAC was initiated 5 hours postingestion. At 6.25 hours postingestion, the acetaminophen concentration was 281 µg/mL. Following administration of intravenous NAC for 21 hours, therapy was discontinued despite a residual acetaminophen concentration of 116 µg/mL. The patient experienced hepatotoxicity, coagulopathy, and renal injury. Pharmacokinetic analysis revealed significantly prolonged acetaminophen absorption and a second peak acetaminophen concentration of 228 µg/mL approximately 48 hours postingestion. Direct in-hospital monitoring of the patient made a second ingestion unlikely.

DISCUSSION: Acetaminophen overdose is usually effectively managed with NAC. Patients with massive ingestions may have altered absorption kinetics due to acetaminophen's solubility being exceeded, physiologically or chemically altered gastrointestinal emptying or motility, or other factors. These patients may benefit from gastrointestinal decontamination and prolonged NAC therapy.

CONCLUSIONS: In patients with massive acetaminophen ingestion, erratic absorption may occur, and toxic serum concentrations may persist beyond a standard 21-hour course of intravenous NAC therapy. Acetaminophen concentrations and aminotransferase levels should be evaluated at the completion of the intravenous NAC infusion to ensure complete elimination of acetaminophen and absence of hepatotoxicity and to exclude the need for prolonged treatment.

Key Words: acetaminophen, hepatotoxicity, N-acetylcysteine

Published Online, July 15, 2008. www.theannals.com, DOI 10.1345/aph.1K680





homecopy help contact us subscription past issues search current issue
Copyright © 2008 by Harvey Whitney Books Company.